Procter & Gamble (NYSE:PG) Given “Sector Perform” Rating at Royal Bank of Canada

Procter & Gamble (NYSE:PG)‘s stock had its “sector perform” rating reaffirmed by analysts at Royal Bank of Canada in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $164.00 price target on the stock. Royal Bank of Canada’s price target suggests a potential downside of 3.77% from the company’s previous close.

Other research analysts also recently issued reports about the stock. Stifel Nicolaus raised their price objective on shares of Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a report on Monday, July 22nd. Citigroup raised their price target on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. JPMorgan Chase & Co. raised their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. StockNews.com cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Piper Sandler initiated coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target on the stock. Nine investment analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $176.26.

Procter & Gamble Stock Down 0.5 %

Shares of NYSE PG traded down $0.86 during trading on Monday, hitting $170.42. 312,806 shares of the company traded hands, compared to its average volume of 6,661,414. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. Procter & Gamble has a fifty-two week low of $142.50 and a fifty-two week high of $177.94. The firm has a market capitalization of $402.21 billion, a price-to-earnings ratio of 27.85, a P/E/G ratio of 3.74 and a beta of 0.41. The business’s fifty day moving average is $171.77 and its 200 day moving average is $167.24.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The company’s revenue for the quarter was down .6% on a year-over-year basis. During the same quarter last year, the business posted $1.83 EPS. Equities research analysts predict that Procter & Gamble will post 6.97 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Susan Street Whaley sold 634 shares of the business’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the transaction, the insider now owns 19,341 shares in the company, valued at $3,319,882.65. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Susan Street Whaley sold 634 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares of the company’s stock, valued at $3,319,882.65. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO R. Alexandra Keith sold 3,373 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $170.00, for a total transaction of $573,410.00. Following the transaction, the chief executive officer now directly owns 21,513 shares of the company’s stock, valued at $3,657,210. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 383,194 shares of company stock valued at $65,140,718. 0.17% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Procter & Gamble

Institutional investors have recently made changes to their positions in the company. Acorn Creek Capital LLC grew its stake in Procter & Gamble by 2.8% in the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after acquiring an additional 59 shares during the period. Alera Investment Advisors LLC boosted its position in shares of Procter & Gamble by 1.2% during the 1st quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after acquiring an additional 60 shares during the last quarter. Hudson Value Partners LLC boosted its position in shares of Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after acquiring an additional 60 shares during the last quarter. Traveka Wealth LLC boosted its position in shares of Procter & Gamble by 1.7% during the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after acquiring an additional 60 shares during the last quarter. Finally, Fiduciary Alliance LLC boosted its position in shares of Procter & Gamble by 2.8% during the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after acquiring an additional 61 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.